Pro-Dex Inc
$ 42.23
1.20%
16 Jan - close price
- Market Cap 138,515,000 USD
- Current Price $ 42.23
- High / Low $ 43.38 / 41.73
- Stock P/E 12.72
- Book Value 12.73
- EPS 3.32
- Next Earning Report 2026-01-29
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.11 %
- ROE 0.31 %
- 52 Week High 70.26
- 52 Week Low 23.47
About
Pro-Dex Inc. (PDEX) is a prominent developer and manufacturer of innovative powered surgical instruments tailored for original equipment manufacturers in the global medical device industry. Based in Irvine, California, the company leverages advanced engineering and precision manufacturing techniques to enhance surgical outcomes and address the evolving needs of healthcare providers. With a strong emphasis on research and development, Pro-Dex is strategically positioned to navigate the complexities of a fast-paced healthcare landscape, ensuring continued growth and competitive advantage.
Analyst Target Price
$56.00
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-10-30 | 2025-09-04 | 2025-05-01 | 2025-01-30 | 2024-10-31 | 2024-09-05 | 2024-05-02 | 2024-02-08 | 2023-11-02 | 2023-09-29 | 2023-05-04 | 2023-02-02 |
| Reported EPS | 1.4 | 0.36 | 0.85 | 0.61 | 0.75 | 0.46 | 0.19 | 0.14 | -0.17 | 0.42 | 0.36 | 0.24 |
| Estimated EPS | 0.5 | 0.47 | 0.47 | 0.38 | 0.29 | 0.35 | 0.35 | 0.35 | 0.32 | 0.33 | 0.26 | 0.29 |
| Surprise | 0.9 | -0.11 | 0.38 | 0.23 | 0.46 | 0.11 | -0.16 | -0.21 | -0.49 | 0.09 | 0.1 | -0.05 |
| Surprise Percentage | 180% | -23.4043% | 80.8511% | 60.5263% | 158.6207% | 31.4286% | -45.7143% | -60% | -153.125% | 27.2727% | 38.4615% | -17.2414% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-01-29 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: PDEX
2026-01-18 00:57:42
Pro-Dex (PDEX) manufactures powered surgical instruments and industrial air motors, serving niche markets in orthopedics, CMF, and thoracic procedures. Despite currently having a high concentration of revenue from a single customer (78% of sales), the company is considered undervalued due to a significant recent decline in share price. The author holds a bullish stance on the stock, citing its compelling valuation multiples and positive cash flow.
2026-01-12 09:27:08
D.A. Davidson & CO. significantly increased its stake in Pro-Dex, Inc. (NASDAQ:PDEX) by 152.3% in the third quarter, now owning 26,073 shares worth $883,000. Other institutional investors also adjusted their holdings in the medical instruments supplier. Analysts have a "Moderate Buy" consensus rating for Pro-Dex with an average target price of $56.00.
2025-12-22 16:09:29
Pro-Dex Inc. (NASDAQ:PDEX) stock surged 6% in premarket trading after the medical device manufacturer announced a three-year contract extension with its largest customer. The agreement extends through December 31, 2028, and includes minimum purchase volume commitments for 2026 and 2027, securing a stable revenue stream for the company. Pro-Dex specializes in surgical drivers and shavers, utilizing patented adaptive torque-limiting software and proprietary sealing solutions.
2025-12-22 16:09:15
Pro-Dex Inc (NASDAQ:PDEX) stock surged 6% in premarket trading after announcing a three-year contract extension with its largest customer. The agreement, originally set to expire on December 31, 2025, now continues through December 31, 2028, and includes minimum purchase volume commitments for 2026 and 2027, securing a stable revenue stream for the medical device manufacturer.
2025-12-22 15:16:00
Pro-Dex Inc (NASDAQ:PDEX) stock increased 6% in premarket trading after the medical device manufacturer announced a three-year contract extension with its largest customer. The contract, originally ending December 31, 2025, has been extended through December 31, 2028, and includes minimum purchase volume commitments for 2026 and 2027. This extension secures a stable revenue stream for Pro-Dex from a key customer and positions the company for continued revenue growth.
2025-12-22 14:09:32
Pro-Dex Inc (NASDAQ:PDEX) stock jumped 6% in premarket trading after announcing a three-year contract extension with its largest customer. The agreement, now through December 31, 2028, includes minimum purchase volume commitments and is seen as a significant win for the medical device manufacturer, providing revenue stability and growth visibility. This extension will culminate in over fifteen years of collaboration with this key customer.
